4//SEC Filing
Jorgensen Nathan D. 4
Accession 0001209191-23-014918
CIK 0001817229other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 6:35 PM ET
Size
8.5 KB
Accession
0001209191-23-014918
Insider Transaction Report
Form 4
Jorgensen Nathan D.
Chief Financial Officer
Transactions
- Tax Payment
Common Stock
2023-03-01$5.51/sh−6,310$34,768→ 154,459 total
Footnotes (1)
- [F1]Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units ("RSUs").
Documents
Issuer
Vor Biopharma Inc.
CIK 0001817229
Entity typeother
Related Parties
1- filerCIK 0001842523
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 6:35 PM ET
- Size
- 8.5 KB